Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080910079> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W3080910079 endingPage "3461" @default.
- W3080910079 startingPage "3458" @default.
- W3080910079 abstract "The aim of the present study was to predict the interaction of 4-dichloro-5-sulfamoyl benzoic acid (DSBA) derived from Streptomyces sp. VITBRK3 with the drug target enzymes of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin resistant Enterococci (VRE) strains procured from ATCC. Two proteins dihydropteroate synthetase (DPS) and dihydrofolate reductase (DFR) were chosen as drug targets. The well-known folic acid synthesis inhibitor amino salicylic acid (ASA) was taken as a positive control. AutoDock 4.2.1 was used to perform the protein-ligand docking analysis. DSBA showed least binding energy of –6.99 kcal/mol and inhibition constant of 7.5 µM and formed 8 hydrogen bonds with DFR. DSBA showed least binding energy of -5.6 kcal/mol and inhibition constant of 78.58 µM and formed 7 hydrogen bonds with DPS. ASA showed the binding energy of –4.97 kcal/mol, and inhibition constant of 225.9 µM and formed 5 hydrogen bonds with DPS protein. It showed the binding energy of –4.68 kcal/mol, and inhibition constant of 371.32 µM and formed 4 hydrogen bonds with DFR protein. DSBA has qualified CMC rule, lead like rule and Lipinski’s rule of five. The compound DSBA does not possess any carcinogenic effect in rat or mouse model. Osiris Property Explorer analysis suggested that, DSBA does not possess any major side effects and is a suitable drug candidate. Pre ADMET analysis also suggests that, the lead compound, DSBA is a suitable drug candidate. The results of this study suggest that the antimicrobial activity of DSBA against MRSA and VRE strains is due to its inhibition over bacterial cell wall folic acid biosynthesis." @default.
- W3080910079 created "2020-09-01" @default.
- W3080910079 creator A5042642146 @default.
- W3080910079 creator A5048245663 @default.
- W3080910079 date "2016-09-30" @default.
- W3080910079 modified "2023-09-26" @default.
- W3080910079 title "Marine Streptomyces-derived Antibacterial Compound [2, 4-Dichloro-5-sulfamoyl benzoic acid] for MRSA and VRE Strains" @default.
- W3080910079 doi "https://doi.org/10.37285/ijpsn.2016.9.5.3" @default.
- W3080910079 hasPublicationYear "2016" @default.
- W3080910079 type Work @default.
- W3080910079 sameAs 3080910079 @default.
- W3080910079 citedByCount "0" @default.
- W3080910079 crossrefType "journal-article" @default.
- W3080910079 hasAuthorship W3080910079A5042642146 @default.
- W3080910079 hasAuthorship W3080910079A5048245663 @default.
- W3080910079 hasConcept C104317684 @default.
- W3080910079 hasConcept C107824862 @default.
- W3080910079 hasConcept C112887158 @default.
- W3080910079 hasConcept C159110408 @default.
- W3080910079 hasConcept C178790620 @default.
- W3080910079 hasConcept C185592680 @default.
- W3080910079 hasConcept C2775905019 @default.
- W3080910079 hasConcept C2778844314 @default.
- W3080910079 hasConcept C2780152424 @default.
- W3080910079 hasConcept C32786932 @default.
- W3080910079 hasConcept C32909587 @default.
- W3080910079 hasConcept C41685203 @default.
- W3080910079 hasConcept C41847442 @default.
- W3080910079 hasConcept C55493867 @default.
- W3080910079 hasConcept C71240020 @default.
- W3080910079 hasConcept C71924100 @default.
- W3080910079 hasConceptScore W3080910079C104317684 @default.
- W3080910079 hasConceptScore W3080910079C107824862 @default.
- W3080910079 hasConceptScore W3080910079C112887158 @default.
- W3080910079 hasConceptScore W3080910079C159110408 @default.
- W3080910079 hasConceptScore W3080910079C178790620 @default.
- W3080910079 hasConceptScore W3080910079C185592680 @default.
- W3080910079 hasConceptScore W3080910079C2775905019 @default.
- W3080910079 hasConceptScore W3080910079C2778844314 @default.
- W3080910079 hasConceptScore W3080910079C2780152424 @default.
- W3080910079 hasConceptScore W3080910079C32786932 @default.
- W3080910079 hasConceptScore W3080910079C32909587 @default.
- W3080910079 hasConceptScore W3080910079C41685203 @default.
- W3080910079 hasConceptScore W3080910079C41847442 @default.
- W3080910079 hasConceptScore W3080910079C55493867 @default.
- W3080910079 hasConceptScore W3080910079C71240020 @default.
- W3080910079 hasConceptScore W3080910079C71924100 @default.
- W3080910079 hasIssue "5" @default.
- W3080910079 hasLocation W30809100791 @default.
- W3080910079 hasOpenAccess W3080910079 @default.
- W3080910079 hasPrimaryLocation W30809100791 @default.
- W3080910079 hasRelatedWork W1804108105 @default.
- W3080910079 hasRelatedWork W2051525362 @default.
- W3080910079 hasRelatedWork W2584655547 @default.
- W3080910079 hasRelatedWork W2600153891 @default.
- W3080910079 hasRelatedWork W2899529815 @default.
- W3080910079 hasRelatedWork W2913918472 @default.
- W3080910079 hasRelatedWork W2954898935 @default.
- W3080910079 hasRelatedWork W4205156962 @default.
- W3080910079 hasRelatedWork W4316928435 @default.
- W3080910079 hasRelatedWork W2182717894 @default.
- W3080910079 hasVolume "9" @default.
- W3080910079 isParatext "false" @default.
- W3080910079 isRetracted "false" @default.
- W3080910079 magId "3080910079" @default.
- W3080910079 workType "article" @default.